Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
4.550
-0.510 (-10.08%)
Nov 5, 2026, 4:00 PM EST - Market closed

Entrada Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
112.2490.39101.2167.645.16291.06
Short-Term Investments
80.78205.3318.79284.37143.56-
Cash & Short-Term Investments
193.02295.7420351.97188.71291.06
Cash Growth
-40.95%-29.59%19.33%86.51%-35.16%645.46%
Accounts Receivable
0.841.183.685.88--
Other Receivables
-1.41.81.70.6-
Receivables
0.842.585.487.580.6-
Prepaid Expenses
9.17.3214.5610.2220.567.64
Restricted Cash
-0.66----
Total Current Assets
202.95306.25440.04369.77209.88298.7
Property, Plant & Equipment
60.5167.7682.0592.6833.026.26
Other Long-Term Assets
3.423.364.236.749.160.87
Total Assets
266.88377.38526.32469.19252.06305.83

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.872.294.263.285.990.71
Accrued Expenses
16.2816.5112.310.327.155.53
Current Portion of Leases
4.624.147.567.918.41-
Current Income Taxes Payable
--0.674.02--
Current Unearned Revenue
0.10.3413.65132.26--
Other Current Liabilities
-1.171.0410.430.49
Total Current Liabilities
25.8624.4539.48158.821.976.72
Long-Term Leases
42.6946.7951.6560.3217.53-
Long-Term Unearned Revenue
--6.517.72--
Other Long-Term Liabilities
-----0.4
Total Liabilities
68.5671.2597.64226.8339.57.12

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
593.69578.57558.06437.13402.89392.38
Retained Earnings
-395.32-273.09-129.34-194.97-188.29-93.67
Comprehensive Income & Other
-0.060.65-0.040.2-2.06-
Total Common Equity
198.33306.13428.68242.36212.55298.72
Shareholders' Equity
198.33306.13428.68242.36212.55298.72
Total Liabilities & Equity
266.88377.38526.32469.19252.06305.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
47.3150.9359.2168.2325.94-
Net Cash (Debt)
145.7244.77360.79283.74162.78291.06
Net Cash Growth
-46.91%-32.16%27.16%74.31%-44.08%645.46%
Net Cash Per Share
3.475.929.258.595.2046.44
Filing Date Shares Outstanding
39.153635.6332.3333.0831.25
Total Common Shares Outstanding
39.153635.6132.1731.3931.22
Working Capital
177.09281.8400.56210.98187.9291.98
Book Value Per Share
5.078.5012.047.536.779.57
Tangible Book Value
198.33306.13428.68242.36212.55298.72
Tangible Book Value Per Share
5.078.5012.047.536.779.57
Machinery
-17.0618.4215.268.546.12
Construction In Progress
----0.58-
Leasehold Improvements
-0.191.931.861.861.56
SEC Filings: 10-K · 10-Q